These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33363284)

  • 1. The Assessment of Convalescent Plasma Efficacy against COVID-19.
    Casadevall A; Grossman BJ; Henderson JP; Joyner MJ; Shoham S; Pirofski LA; Paneth N
    Med; 2020 Dec; 1(1):66-77. PubMed ID: 33363284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of convalescent plasma in the therapy of COVID-19].
    Körper S; Seifried E; Schrezenmeier H
    Dtsch Med Wochenschr; 2023 Mar; 148(7):423-426. PubMed ID: 36940693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds.
    Larkey NE; Ewaisha R; Lasho MA; Roforth MM; Granger D; Jerde CR; Wu L; Gorsh A; Klassen SA; Senefeld JW; Joyner MJ; Baumann NA; Theel ES; Mills JR
    Microbiol Spectr; 2022 Aug; 10(4):e0115422. PubMed ID: 35862939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy.
    Casadevall A; Joyner MJ; Pirofski LA; Senefeld JW; Shoham S; Sullivan D; Paneth N; Focosi D
    Expert Rev Respir Med; 2023 May; 17(5):381-395. PubMed ID: 37129285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2.
    Burnouf T; Gathof B; Bloch EM; Bazin R; de Angelis V; Patidar GK; Rastvorceva RMG; Oreh A; Goel R; Rahimi-Levene N; Hindawi S; Al-Riyami AZ; So-Osman C;
    Transfus Med Rev; 2022 Jul; 36(3):125-132. PubMed ID: 35879213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
    Bloch EM; Tobian AAR; Shoham S; Hanley DF; Gniadek TJ; Cachay ER; Meisenberg BR; Kafka K; Marshall C; Heath SL; Shenoy A; Paxton JH; Levine A; Forthal D; Fukuta Y; Huaman MA; Ziman A; Adamski J; Gerber J; Cruser D; Kassaye SG; Mosnaim GS; Patel B; Metcalf RA; Anjan S; Reisler RB; Yarava A; Lane K; McBee N; Gawad A; Raval JS; Zand M; Abinante M; Broderick PB; Casadevall A; Sullivan D; Gebo KA
    Transfusion; 2022 May; 62(5):933-941. PubMed ID: 35352362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname.
    Bihariesingh-Sanchit R; Bansie R; Ramdhani N; Mangroo R; Bustamente D; Diaz E; Fung A Foek C; Thakoer I; Vreden S; Choudhry Z; van 't Wout AB; Diavatopoulos DA; Nierich AP
    mBio; 2023 Apr; 14(2):e0337922. PubMed ID: 36815780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
    Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
    BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID 19 convalescent plasma: Is there still a place for CCP?
    Moog R
    Transfus Apher Sci; 2023 Apr; 62(2):103680. PubMed ID: 36870907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
    De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
    Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are convalescent plasma stocks collected during former COVID-19 waves still effective against current SARS-CoV-2 variants?
    Focosi D; Franchini M; Joyner MJ; Casadevall A
    Vox Sang; 2022 May; 117(5):641-646. PubMed ID: 35023163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.
    Habtehyimer F; Zhu X; Redd AD; Gebo KA; Abraham AG; Patel EU; Laeyendecker O; Gniadek TJ; Fernandez RE; Baker OR; Ram M; Cachay ER; Currier JS; Fukuta Y; Gerber JM; Heath SL; Meisenberg B; Huaman MA; Levine AC; Shenoy A; Anjan S; Blair JE; Cruser D; Forthal DN; Hammitt LL; Kassaye S; Mosnaim GS; Patel B; Paxton JH; Raval JS; Sutcliffe CG; Abinante M; Oei KS; Cluzet V; Cordisco ME; Greenblatt B; Rausch W; Shade D; Gawad AL; Klein SL; Pekosz A; Shoham S; Casadevall A; Bloch EM; Hanley D; Tobian AAR; Sullivan DJ
    Microbiol Spectr; 2024 Jan; 12(1):e0328623. PubMed ID: 38009954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.
    Bégin P; Callum J; Heddle NM; Cook R; Zeller MP; Tinmouth A; Fergusson DA; Cushing MM; Glesby MJ; Chassé M; Devine DV; Robitalle N; Bazin R; Shehata N; Finzi A; McGeer A; Scales DC; Schwartz L; Turgeon AF; Zarychanski R; Daneman N; Carl R; Amorim L; Gabe C; Ellis M; Sachais BS; Loftsgard KC; Jamula E; Carruthers J; Duncan J; Lucier K; Li N; Liu Y; Armali C; Kron A; Modi D; Auclair MC; Cerro S; Avram M; Arnold DM
    Trials; 2021 May; 22(1):323. PubMed ID: 33947446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality.
    Casadevall A; Dragotakes Q; Johnson PW; Senefeld JW; Klassen SA; Wright RS; Joyner MJ; Paneth N; Carter RE
    Elife; 2021 Jun; 10():. PubMed ID: 34085928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The art of the possible in approaching efficacy trials for COVID19 convalescent plasma.
    Focosi D; Farrugia A
    Int J Infect Dis; 2021 Jan; 102():244-246. PubMed ID: 33130197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma.
    Sullivan D; Casadevall A
    mBio; 2023 Jun; 14(3):e0042823. PubMed ID: 37039667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
    Bar KJ; Shaw PA; Choi GH; Aqui N; Fesnak A; Yang JB; Soto-Calderon H; Grajales L; Starr J; Andronov M; Mastellone M; Amonu C; Feret G; DeMarshall M; Buchanan M; Caturla M; Gordon J; Wanicur A; Monroy MA; Mampe F; Lindemuth E; Gouma S; Mullin AM; Barilla H; Pronina A; Irwin L; Thomas R; Eichinger RA; Demuth F; Luning Prak ET; Pascual JL; Short WR; Elovitz MA; Baron J; Meyer NJ; Degnan KO; Frank I; Hensley SE; Siegel DL; Tebas P
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34788233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy.
    Herman JD; Wang C; Burke JS; Zur Y; Compere H; Kang J; Macvicar R; Taylor S; Shin S; Frank I; Siegel D; Tebas P; Choi GH; Shaw PA; Yoon H; Pirofski LA; Julg BD; Bar KJ; Lauffenburger D; Alter G
    Cell Rep Med; 2022 Nov; 3(11):100811. PubMed ID: 36351430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 convalescent plasma.
    Tobian AAR; Cohn CS; Shaz BH
    Blood; 2022 Jul; 140(3):196-207. PubMed ID: 34695186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.